Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection

Paul Hengster, Mark D. Pescovitz, Debra Hyatt, Raimund Margreiter, Lars Bäckman, Francois Berthoux, Andrew Bradley, Ginny Bumgardner, James Burdick, Vincenzo Cambi, Gary Chan, Bernard Charpentier, Pierre Daloze, Henrik Ekberg, Göran Gannedahl, Robert Gaston, Phillip Halloran, Ian Hardie, Ingeborg Hauser, Robert JohnsonPaul Keown, Michèle Kessler, Bryce Kiberd, Robert Kirkman, Andrew Lazarovits, Arthur J. Matas, Ferdinand Mühlbacher, Bjorn Nashan, John Neylan, Nils Persson, Mark Pescovitz, Guiseppe Piccoli, Rudolf Pichlmayr, Claudio Ponticelli, Stuart Rodgers, Michael E. Shapiro, David Tiller, Gunnar Tufveson, Gunnar Tyden, Yves Vanrentergehm, Antonio Vercellone, Paul Vialtel, Flavio Vincenti, Samuel Weinstein, Alan Wilkinson

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)
Original languageEnglish
Pages (from-to)310-313
Number of pages4
JournalTransplantation
Volume68
Issue number2
DOIs
Publication statusPublished - Jul 27 1999
Externally publishedYes

ASJC Scopus Subject Areas

  • Transplantation

Fingerprint

Dive into the research topics of 'Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection'. Together they form a unique fingerprint.

Cite this